What data is needed today to deal with cellulitis and necrotizing fasciitis?

Authors
Citation
C. Cazorla, What data is needed today to deal with cellulitis and necrotizing fasciitis?, MED MAL INF, 30, 2000, pp. 389S-398S
Citations number
105
Categorie Soggetti
Clinical Immunolgy & Infectious Disease
Journal title
MEDECINE ET MALADIES INFECTIEUSES
ISSN journal
0399077X → ACNP
Volume
30
Year of publication
2000
Supplement
5
Pages
389S - 398S
Database
ISI
SICI code
0399-077X(200012)30:<389S:WDINTT>2.0.ZU;2-0
Abstract
Cellulitis and necrotizing fasciitis can be distinguished by the depth of t he cutaneous lesion and classically by the different bacteria implicated Th is classification is not taken into account by the practitioner because of a similar therapeutic strategy. That is why most authors used a single titl e: necrotizing soft tissue infection. The potential severity of these infec tions required a quick diagnosis to decrease the risk of mortality and seve re functional consequences. The analysis of the literature doesn't allow to establish the incidence of these infections. It was demonstrated that infe ctions due to Streptococcus serogroup A increased over the last few years, thanks to a specific surveillance system. Risk factors leading to these inf ections are: cutaneous trauma, age, diabetes, varicella in children, contac t with people infected by Streptococcus. The most recent studies demonstrat ed a frequent polymicrobism of the infections, with anaerobes, Streptococcu s, Staphylococcus, and gram-negative rods. At the onset of the disease, the diagnosis is difficult to establish. Pain, induration of tissues, a rapid evolution, the inefficacy of antibiotic treatment suggest the diagnosis of necrotizing infection. MRI, when available, is a good technique to reveal t he depth of the infection and necrosis. Surgery will confirm the diagnosis and allow for debridement of necrotized tissues. A delayed surgery increase s the mortality risk factor; as stated in numerous studies. (C) 2000 Editio ns scientifiques et medicales Elsevier SAS.